Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Maria Eugenia Davola & Karen Louise Mossman. (2019) Oncolytic viruses: how “lytic” must they be for therapeutic efficacy?. OncoImmunology 8:6.
Read now
Read now
Lino E. Torres-Domínguez & Grant McFadden. (2019) Poxvirus oncolytic virotherapy. Expert Opinion on Biological Therapy 19:6, pages 561-573.
Read now
Read now
Jonathan G. Pol, Sarah Lévesque, Samuel T. Workenhe, Shashi Gujar, Fabrice Le Boeuf, Derek R. Clements, Jean-Eudes Fahrner, Laetitia Fend, John C. Bell, Karen L. Mossman, Jitka Fucikova, Radek Spisek, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2018) Trial Watch: Oncolytic viro-immunotherapy of hematologic and solid tumors. OncoImmunology 7:12.
Read now
Read now
Articles from other publishers (29)
Sathiamoorthi Thangavelu, Saikishore Ramanthan, Palanivel Velmurugan & Ranjithkumar Dhandapani. 2023. Viral Infections and Antiviral Therapies. Viral Infections and Antiviral Therapies
143
168
.
Maike Delic, Veronika Boeswald, Katrin Goepfert, Petra Pabst & Markus Moehler. (2022) In vitro Characterization of Enhanced Human Immune Responses by GM-CSF Encoding HSV-1-Induced Melanoma Cells. OncoTargets and Therapy Volume 15, pages 1291-1307.
Crossref
Crossref
Olga S. Troitskaya, Diana D. Novak, Vladimir A. Richter & Olga A. Koval. (2022) Immunogenic Cell Death in Cancer Therapy. Acta Naturae 14:1, pages 40-53.
Crossref
Crossref
Sang-In Kim, Shyambabu Chaurasiya, Venkatesh Sivanandam, Seonah Kang, Anthony K. Park, Jianming Lu, Annie Yang, Zhifang Zhang, Isabella A. Bagdasarian, Yanghee Woo, Joshua T. Morgan, Zhirong Yin, Yuman Fong & Susanne G. Warner. (2022) Priming stroma with a vitamin D analog to optimize viroimmunotherapy for pancreatic cancer. Molecular Therapy - Oncolytics 24, pages 864-872.
Crossref
Crossref
Dirk M. Nettelbeck, Mathias F. Leber, Jennifer Altomonte, Assia Angelova, Julia Beil, Susanne Berchtold, Maike Delic, Jürgen Eberle, Anja Ehrhardt, Christine E. Engeland, Henry Fechner, Karsten Geletneky, Katrin Goepfert, Per Sonne Holm, Stefan Kochanek, Florian Kreppel, Lea Krutzke, Florian Kühnel, Karl Sebastian Lang, Antonio Marchini, Markus Moehler, Michael D. Mühlebach, Ulrike Naumann, Roman Nawroth, Jürg Nüesch, Jean Rommelaere, Ulrich M. Lauer & Guy Ungerechts. (2021) Virotherapy in Germany—Recent Activities in Virus Engineering, Preclinical Development, and Clinical Studies. Viruses 13:8, pages 1420.
Crossref
Crossref
Ángela-Patricia Hernández, Pablo Juanes-Velasco, Alicia Landeira-Viñuela, Halin Bareke, Enrique Montalvillo, Rafael Góngora & Manuel Fuentes. (2021) Restoring the Immunity in the Tumor Microenvironment: Insights into Immunogenic Cell Death in Onco-Therapies. Cancers 13:11, pages 2821.
Crossref
Crossref
Annalisa Chianese, Biagio Santella, Annalisa Ambrosino, Debora Stelitano, Luca Rinaldi, Massimiliano Galdiero, Carla Zannella & Gianluigi Franci. (2021) Oncolytic Viruses in Combination Therapeutic Approaches with Epigenetic Modulators: Past, Present, and Future Perspectives. Cancers 13:11, pages 2761.
Crossref
Crossref
Eilam Yeini, Paula Ofek, Nitzan Albeck, Daniel Rodriguez Ajamil, Lena Neufeld, Anat Eldar‐Boock, Ron Kleiner, Daniella Vaskovich, Shani Koshrovski‐Michael, Sahar Israeli Dangoor, Adva Krivitsky, Christian Burgos Luna, Gal Shenbach‐Koltin, Miki Goldenfeld, Ori Hadad, Galia Tiram & Ronit Satchi‐Fainaro. (2020) Targeting Glioblastoma: Advances in Drug Delivery and Novel Therapeutic Approaches. Advanced Therapeutics 4:1, pages 2000124.
Crossref
Crossref
Tiphaine Delaunay, Joelle Nader, Marion Grard, Isabelle Farine, Vera Hedwig, Johann Foloppe, Thibaut Blondy, Mathilde Violland, Daniel Pouliquen, Marc Grégoire, Nicolas Boisgerault, Philippe Erbs & Jean-François Fonteneau. (2020) High Oncolytic Activity of a Double-Deleted Vaccinia Virus Copenhagen Strain against Malignant Pleural Mesothelioma. Molecular Therapy - Oncolytics 18, pages 573-578.
Crossref
Crossref
Anna Maria Malfitano, Sarah Di Somma, Carmelina Antonella Iannuzzi, Francesca Pentimalli & Giuseppe Portella. (2020) Virotherapy: From single agents to combinatorial treatments. Biochemical Pharmacology 177, pages 113986.
Crossref
Crossref
Xueke Wang, Xiaoyan Shao, Linaer Gu, Ke Jiang, Sitong Wang, Jianhua Chen, Juemin Fang, Xianling Guo, Min Yuan, Ji Shi, Chan Ding, Songshu Meng & Qing Xu. (2020) Targeting STAT3 enhances NDV‐induced immunogenic cell death in prostate cancer cells. Journal of Cellular and Molecular Medicine 24:7, pages 4286-4297.
Crossref
Crossref
Shyambabu Chaurasiya, Nanhai G. Chen, Jianming Lu, Nikolas Martin, Yinan Shen, Sang-In Kim, Susanne G. Warner, Yanghee Woo & Yuman Fong. (2019) A chimeric poxvirus with J2R (thymidine kinase) deletion shows safety and anti-tumor activity in lung cancer models. Cancer Gene Therapy 27:3-4, pages 125-135.
Crossref
Crossref
Daylen Aguilar-NoriegaDr.Dr. & Silvio PereaDr.Dr.. (2019) Immunogenic Cell Death: An opportunity for Clinical Oncology?. Bionatura 4:4, pages 958-959.
Crossref
Crossref
A. O. Sitkovskaya, E. Yu. Zlatnik, I. V. Mezhevova, E. S. Bondarenko, S. A. Kolpakov, E. P. Kolpakova & I. A. Novikova. (2020) The Effect of Oncolytic Reovirus P-92 on Dendritic Cell Maturation and Generation of Tumor-Specific Lymphocytes in vitro. Cell and Tissue Biology 13:6, pages 434-438.
Crossref
Crossref
Margareth R.C. Marques, Qiuyi Choo, Mukul Ashtikar, Thais Correa Rocha, Susanne Bremer-Hoffmann & Matthias G. Wacker. (2019) Nanomedicines - Tiny particles and big challenges. Advanced Drug Delivery Reviews 151-152, pages 23-43.
Crossref
Crossref
Johann Foloppe, Juliette Kempf, Nicolas Futin, Jacqueline Kintz, Pascale Cordier, Christelle Pichon, Annie Findeli, Fabien Vorburger, Eric Quemeneur & Philippe Erbs. (2019) The Enhanced Tumor Specificity of TG6002, an Armed Oncolytic Vaccinia Virus Deleted in Two Genes Involved in Nucleotide Metabolism. Molecular Therapy - Oncolytics 14, pages 1-14.
Crossref
Crossref
Céline Coppard, Dalil Hannani, Marion Humbert, Virginie Gauthier, Joel Plumas, Etienne Merlin, Françoise Gabert & Laurence Chaperot. (2019) In vitro PUVA treatment triggers calreticulin exposition and HMGB1 release by dying T lymphocytes in GVHD: New insights in extracorporeal photopheresis. Journal of Clinical Apheresis 34:4, pages 450-460.
Crossref
Crossref
Patricia Kleinpeter, Christelle Remy-Ziller, Eline Winter, Murielle Gantzer, Virginie Nourtier, Juliette Kempf, Julie Hortelano, Doris Schmitt, Huguette Schultz, Michel Geist, Catherine Brua, Chantal Hoffmann, Yasmin Schlesinger, Dominique Villeval, Christine Thioudellet, Philippe Erbs, Johann Foloppe, Nathalie Silvestre, Laetitia Fend, Eric Quemeneur & Jean-Baptiste Marchand. (2019) By Binding CD80 and CD86, the Vaccinia Virus M2 Protein Blocks Their Interactions with both CD28 and CTLA4 and Potentiates CD80 Binding to PD-L1. Journal of Virology 93:11.
Crossref
Crossref
Susanne G. Warner, Sang-In Kim, Shyambabu Chaurasiya, Michael P. O’Leary, Jianming Lu, Venkatesh Sivanandam, Yanghee Woo, Nanhai G. Chen & Yuman Fong. (2019) A Novel Chimeric Poxvirus Encoding hNIS Is Tumor-Tropic, Imageable, and Synergistic with Radioiodine to Sustain Colon Cancer Regression. Molecular Therapy - Oncolytics 13, pages 82-92.
Crossref
Crossref
Katrin Goepfert, Christiane Dinsart, Jean Rommelaere, Friedrich Foerster & Markus Moehler. (2019) Rational Combination of Parvovirus H1 With CTLA-4 and PD-1 Checkpoint Inhibitors Dampens the Tumor Induced Immune Silencing. Frontiers in Oncology 9.
Crossref
Crossref
Marine Ricordel, Johann Foloppe, Christelle Pichon, Annie Findeli, Caroline Tosch, Pascale Cordier, Sandrine Cochin, Eric Quémeneur, Christelle Camus-Bouclainville, Stéphane Bertagnoli & Philippe Erbs. (2018) Oncolytic properties of non-vaccinia poxviruses. Oncotarget 9:89, pages 35891-35906.
Crossref
Crossref
Lien Van Hoecke, Sandra Van Lint, Kenny Roose, Alexander Van Parys, Peter Vandenabeele, Johan Grooten, Jan Tavernier, Stefaan De Koker & Xavier Saelens. (2018) Treatment with mRNA coding for the necroptosis mediator MLKL induces antitumor immunity directed against neo-epitopes. Nature Communications 9:1.
Crossref
Crossref
Marine Ricordel, Johann Foloppe, Delphine Antoine, Annie Findeli, Juliette Kempf, Pascale Cordier, Aude Gerbaud, Benoit Grellier, Monika Lusky, Eric Quemeneur & Philippe Erbs. (2018) Vaccinia Virus Shuffling: deVV5, a Novel Chimeric Poxvirus with Improved Oncolytic Potency. Cancers 10:7, pages 231.
Crossref
Crossref
Ashley T Chen, Briana LR Samson, Mathieu JF Crupi & John C Bell. (2018) Oncolytic viruses: cytolytic agents, replicating immunotherapeutics or both?. Future Virology 13:7, pages 445-448.
Crossref
Crossref
Katherine Cook, Lindy Durrant & Victoria Brentville. (2018) Current Strategies to Enhance Anti-Tumour Immunity. Biomedicines 6:2, pages 37.
Crossref
Crossref
Jacob P. van Vloten, Samuel T. Workenhe, Sarah K. Wootton, Karen L. Mossman & Byram W. Bridle. (2018) Critical Interactions between Immunogenic Cancer Cell Death, Oncolytic Viruses, and the Immune System Define the Rational Design of Combination Immunotherapies. The Journal of Immunology 200:2, pages 450-458.
Crossref
Crossref
Xiuying Li. (2018) The inducers of immunogenic cell death for tumor immunotherapy. Tumori Journal 104:1, pages 1-8.
Crossref
Crossref
Kristian M. Hargadon. (2017) Strategies to Improve the Efficacy of Dendritic Cell-Based Immunotherapy for Melanoma. Frontiers in Immunology 8.
Crossref
Crossref
Margaret R. DuffyKerry D. FisherLen W. Seymour. (2017) Making Oncolytic Virotherapy a Clinical Reality: The European Contribution. Human Gene Therapy 28:11, pages 1033-1046.
Crossref
Crossref